Bloomberg Law
June 26, 2019, 9:18 AM

Sham Stem Cell Studies Force NIH to Weed Its Research Database

Jeannie Baumann
Jeannie Baumann

For-profit stem cell clinics that had run-ins with the FDA could have a harder time misleading patients into thinking their studies have the government’s seal of approval.

The National Institutes of Health wants to clamp down on for-profit stem cell clinics that market their products as being based on research included in studies at, implying the federal government has endorsed the treatments. The NIH’s National Library of Medicine oversees the repository of more than 300,000 studies posted by companies or investigators but doesn’t monitor individual study records.

The potential changes come after the Food and Drug Administration sought ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.